Companies

Lyra Therapeutics, Inc.

LYRA · CIK 0001327273 · operating

$1.22+2.52%Last updated Mar 3, 6:00 PM

Key Statistics

Valuation

Market Cap$2.25M
P/E
Fwd P/E-1.28
PEG
P/S3.76
P/B
EV/EBITDA-0.36
EV/Rev19.06

Profitability

Gross Margin
Op. Margin-6280.83%
Net Margin-6090.94%
ROE-805.89%
ROA-140.83%
FCF Margin-4716.36%

Financial Health

Current Ratio3.41
Debt/Equity4.72
Free Cash Flow-$72.35M
Div. Yield

Growth & Other

Revenue Growth-1.54%
EPS Growth-13.49%
Beta0.06
52W High$37.5
52W Low$0.906

About Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. (LYRA) is a surgical & medical instruments & apparatus company incorporated in DE, listed on the Nasdaq. With a market capitalization of $2 million, Lyra Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.22, up 2.52% today, with a 52-week range of $1.21–$37.50.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.43$-1.43-13.5%
2023$-1.26$-1.26+31.1%
2022$-1.83$-1.83
2021
2020

Annual Reports (10-K) · 5 filings

Report DateFiledAccession Number
2024-12-312025-03-130000950170-25-038751SEC ↗
2023-12-312024-03-220000950170-24-035047SEC ↗
2022-12-312023-03-290000950170-23-010632SEC ↗
2021-12-312022-03-090001564590-22-009187SEC ↗
2020-12-312021-03-090001564590-21-011767SEC ↗